Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers

Journal of Controlled Release

Volumn 158, Issue 3, 2012, Pages 451-460

  Kim, Jaesung ^a   Kim, Pyung Hwan ^a   Nam, Hye Yeong ^a   Lee, Jung Sun ^b,c   Yun, Chae Ok ^c   Kim, Sung Wan ^a,c  

^a UNIVERSITY OF UTAH   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Adenoviral replication; Bioreducible polymer; Cancer gene therapy; Oncolytic adenovirus

Indexed keywords

ADAPTIVE IMMUNE RESPONSE; ADENOVIRAL REPLICATION; ALTERNATIVE APPROACH; BIODISTRIBUTIONS; BIOREDUCIBLE POLYMER; CANCER GENE THERAPY; CANCER THERAPY; DELIVERY VECTOR; HUMAN CANCER CELLS; ONCOLYTIC ADENOVIRUS; PLASMID DNA; POLYPLEXES; SIMPLE SYSTEM; VIRAL PRODUCTION; VIRAL REPLICATION;

AMINO ACIDS; BIOMOLECULES; CONJUGATED POLYMERS; LINEARIZATION; NUCLEIC ACIDS; ONCOLOGY; POLYPEPTIDES; TUMORS; VIRUSES;

POLYMERS;

ARGININE; ONCOLYTIC ADENOVIRUS; ONCOLYTIC ADENOVIRUS PLASMID DNA; PLASMID DNA; POLY(DISULFIDE AMINE); POLYMER; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ARGININE; CELL LINE, TUMOR; DNA, VIRAL; FEMALE; GENETIC VECTORS; HEK293 CELLS; HUMANS; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, NUDE; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; PLASMIDS; POLYAMINES; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION;

EID: 84859266537     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.12.008     Document Type: Article

References (43)

1. W.W. Zhang, R. Alemany, J. Wang, P.E. Koch, N.G. Ordonez, and J.A. Roth Safety evaluation of Ad5CMV-p53 in vitro and in vivo Hum. Gene Ther. 6 1995 155 164
2. D.S. Shewach, L.K. Zerbe, T.L. Hughes, B.J. Roessler, X.O. Breakefield, and B.L. Davidson Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells Cancer Gene Ther. 1 1994 107 112
3. K.J. Choi, J.H. Kim, Y.S. Lee, J. Kim, B.S. Suh, H. Kim, S. Cho, J.H. Sohn, G.E. Kim, and C.O. Yun Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect Gene Ther. 13 2006 1010 1020 (Pubitemid 43905854)
4. Y.S. Lee, J.H. Kim, K.J. Choi, I.K. Choi, H. Kim, S. Cho, B.C. Cho, and C.O. Yun Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model Clin. Cancer Res. 12 2006 5859 5868 (Pubitemid 44629619)
5. J.Y. Yoo, J.H. Kim, Y.G. Kwon, E.C. Kim, N.K. Kim, H.J. Choi, and C.O. Yun VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth Mol. Ther. 15 2007 295 302 (Pubitemid 46111879)
6. J.Y. Yoo, J.H. Kim, J. Kim, J.H. Huang, S.N. Zhang, Y.A. Kang, H. Kim, and C.O. Yun Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition Gene Ther. 15 2008 635 651 (Pubitemid 351524518)
7. J. Kim, J.Y. Cho, J.H. Kim, K.C. Jung, and C.O. Yun Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy Cancer Gene Ther. 9 2002 725 736 (Pubitemid 34971303)
8. J. Kim, J.H. Kim, K.J. Choi, P.H. Kim, and C.O. Yun E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects Hum. Gene Ther. 18 2007 773 786 (Pubitemid 47502844)
9. Q. Liu, A.K. Zaiss, P. Colarusso, K. Patel, G. Haljan, T.J. Wickham, and D.A. Muruve The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors Hum. Gene Ther. 14 2003 627 643 (Pubitemid 36543435)
10. S.M. Sumida, D.M. Truitt, A.A. Lemckert, R. Vogels, J.H. Custers, M.M. Addo, S. Lockman, T. Peter, F.W. Peyerl, M.G. Kishko, S.S. Jackson, D.A. Gorgone, M.A. Lifton, M. Essex, B.D. Walker, J. Goudsmit, M.J. Havenga, and D.H. Barouch Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein J. Immunol. 174 2005 7179 7185 (Pubitemid 40705685)
11. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392 (Pubitemid 17221789)
12. K.D. Fisher, and L.W. Seymour HPMA copolymers for masking and retargeting of therapeutic viruses Adv. Drug Deliv. Rev. 62 2010 240 245
13. E. Kang, and C.O. Yun Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity BMB Rep. 43 2010 781 788
14. P.H. Kim, E. Kang, J.W. Choi, T.J. Yun, H.K. Park, J.H. Kim, and C.O. Yun Sustained delivery of oncolytic adenovirus in alginate gel for local tumor virotheraphy J. Control. Release 148 2010 e100 e101
15. Y. Park, E. Kang, O.J. Kwon, H.K. Park, J.H. Kim, and C.O. Yun Tumor targeted adenovirus nanocomplex ionically crosslinked by chitosan J. Control. Release 148 2010 e124
16. Y. Park, E. Kang, O.J. Kwon, T. Hwang, H. Park, J.M. Lee, J.H. Kim, and C.O. Yun Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy J. Control. Release 148 2010 75 82
17. J. Kim, P.H. Kim, S.W. Kim, and C.O. Yun Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials Biomaterials 33 2011 1838 1850
18. F. Kreppel, and S. Kochanek Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide Mol. Ther. 16 2008 16 29
19. Y. Jung, H.J. Park, P.H. Kim, J. Lee, W. Hyung, J. Yang, H. Ko, J.H. Sohn, J.H. Kim, Y.M. Huh, C.O. Yun, and S. Haam Retargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cells J. Control. Release 123 2007 164 171 (Pubitemid 47570000)
20. M. Ou, X.L. Wang, R. Xu, C.W. Chang, D.A. Bull, and S.W. Kim Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity Bioconjug. Chem. 19 2008 626 633 (Pubitemid 351431393)
21. T.I. Kim, M. Ou, M. Lee, and S.W. Kim Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems Biomaterials 30 2009 658 664
22. T.I. Kim, and S.W. Kim Bioreducible polymers for gene delivery React. Funct. Polym. 71 2011 344 349
23. T.C. He, S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein A simplified system for generating recombinant adenoviruses Proc. Natl. Acad. Sci. U. S. A. 95 1998 2509 2514 (Pubitemid 28145972)
24. D.J. Palmer, and P. Ng Methods for the production of helper-dependent adenoviral vectors Methods Mol. Biol. 433 2008 33 53
25. O.J. Kwon, E. Kang, S. Kim, and C.O. Yun Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery J. Control. Release 155 2011 317 325
26. A.J. van der Eb Intermediates in type 5 adenovirus DNA replication Virology 51 1973 11 23
27. B.G. van Bergen, P.A. van der Ley, W. van Driel, A.D. van Mansfeld, and P.C. van der Vliet Replication of origin containing adenovirus DNA fragments that do not carry the terminal protein Nucleic Acids Res. 11 1983 1975 1989
28. R.T. Hay The origin of adenovirus DNA replication: minimal DNA sequence requirement in vivo EMBO J. 4 1985 421 426
29. K.L. Berkner, and P.A. Sharp Generation of adenovirus by transfection of plasmids Nucleic Acids Res. 11 1983 6003 6020
30. H.Y. Nam, Y. Lee, M. Lee, S.K. Shin, T.I. Kim, S.W. Kim, D.A. Bull, Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system, J. Control. Release in press.
31. D. Fischer, T. Bieber, Y. Li, H.P. Elsasser, and T. Kissel A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity Pharm. Res. 16 1999 1273 1279 (Pubitemid 29393618)
32. P.H. Kim, T.I. Kim, J.W. Yockman, S.W. Kim, and C.O. Yun The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy Biomaterials 31 2010 1865 1874
33. P.H. Kim, J.H. Sohn, J.W. Choi, Y. Jung, S.W. Kim, S. Haam, and C.O. Yun Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin Biomaterials 32 2011 2314 2326
34. F. Wang, A.C. Puddy, B.C. Mathis, A.G. Montalvo, A.A. Louis, J.L. McMackin, J. Xu, Y. Zhang, C.Y. Tan, T.L. Schofield, J.J. Wolf, and J.A. Lewis Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency Vaccine 23 2005 4500 4508 (Pubitemid 40967978)
35. J. Kim, H.Y. Nam, T.I. Kim, P.H. Kim, J. Ryu, C.O. Yun, and S.W. Kim Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA Biomaterials 32 2011 5158 5166
36. P.H. Kim, J. Kim, T.I. Kim, H.Y. Nam, J.W. Yockman, M. Kim, S.W. Kim, C.O. Yun, Bioreducible polymer-conjugated oncolytic adenovirus for hepatoma-specific therapy via systemic administration, Biomaterials. 32 (2011) 9328-9342
37. R.R. Taghizadeh, and J.L. Sherley CFP and YFP, but not GFP, provide stable fluorescent marking of rat hepatic adult stem cells J. Biomed. Biotechnol. 2008 2008 453590
38. D.A. Muruve, M.J. Barnes, I.E. Stillman, and T.A. Libermann Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo Hum. Gene Ther. 10 1999 965 976 (Pubitemid 29195426)
39. Y. Zhang, N. Chirmule, G.P. Gao, R. Qian, M. Croyle, B. Joshi, J. Tazelaar, and J.M. Wilson Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages Mol. Ther. 3 2001 697 707 (Pubitemid 32509867)
40. K.L. Molnar-Kimber, D.H. Sterman, M. Chang, E.H. Kang, M. ElBash, M. Lanuti, A. Elshami, K. Gelfand, J.M. Wilson, L.R. Kaiser, and S.M. Albelda Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma Hum. Gene Ther. 9 1998 2121 2133 (Pubitemid 28463929)
41. C. Oberholzer, A. Oberholzer, S.K. Tschoeke, R.M. Minter, F.R. Bahjat, D. LaFace, B. Hutchins, and L.L. Moldawer Influence of recombinant adenovirus on liver injury in endotoxicosis and its modulation by IL-10 expression J. Endotoxin Res. 10 2004 393 401 (Pubitemid 39618554)
42. S.M. Ryan, G. Mantovani, X. Wang, D.M. Haddleton, and D.J. Brayden Advances in PEGylation of important biotech molecules: delivery aspects Expert Opin. Drug Deliv. 5 2008 371 383 (Pubitemid 351721718)
43. X. Yao, Y. Yoshioka, T. Morishige, Y. Eto, H. Watanabe, Y. Okada, H. Mizuguchi, Y. Mukai, N. Okada, and S. Nakagawa Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis Gene Ther. 16 2009 1395 1404